$ACTG
ACACIA RESEARCH CORP Stock $actg

$actg Overview Financials Valuation SEC Filings Company Website

2017 Q4 Form 10-Q Financial Statement

#000093454917000055 Filed on November 07, 2017

Income Statement

Concept	2017 Q4	2017 Q3	2016 Q4
Revenue	$3.458M	$36.63M	$21.97M
YoY Change	-84.26%	-43.34%	-41.41%
Cost Of Revenue	$10.00K	$0.00	$3.310M
YoY Change	-99.7%	-100.0%	-57.35%
Gross Profit	$3.450M	$36.63M	$18.66M
YoY Change	-81.51%	-21.75%	-37.26%
Gross Profit Margin	99.77%	99.99%	84.94%
Selling, General & Admin	$310.0K	$24.89M	$13.29M
YoY Change	-97.67%	55.17%	6.58%
% of Gross Profit	8.99%	67.95%	71.22%
Research & Development	$200.0K	$240.0K	$560.0K
YoY Change	-64.29%	-64.18%	-34.88%
% of Gross Profit	5.8%	0.66%	3.0%
Depreciation & Amortization	$5.400M	$5.700M	$6.300M
YoY Change	-14.29%	-12.31%	-52.27%
% of Gross Profit	156.52%	15.56%	33.76%
Operating Expenses	$7.150M	$30.76M	$20.07M
YoY Change	-64.37%	32.7%	-24.8%
Operating Profit	-$7.330M	-$442.0K	-$9.055M
YoY Change	-19.05%	-102.71%	-92.0%
Interest Expense	-$102.5M	$158.9M
YoY Change
% of Operating Profit
Other Income/Expense, Net	-$103.0M	$159.0M	$592.0K
YoY Change	-17490.2%	60829.89%
Pretax Income	-$110.3M	$158.6M	-$8.463M
YoY Change	1203.08%	858.16%	-92.52%
Income Tax	$20.00K	$216.0K	$2.414M
% Of Pretax Income		0.14%
Net Earnings	-$110.2M	$158.5M	-$10.61M
YoY Change	938.57%	2137.57%	-90.85%
Net Earnings / Revenue	-3186.9%	432.57%	-48.3%
Basic Earnings Per Share		$3.13
Diluted Earnings Per Share	-$2.178M	$3.13	-$211.2K
COMMON SHARES
Basic Shares Outstanding	50.60M shares	50.55M shares	50.46M shares
Diluted Shares Outstanding	50.59M shares	50.60M shares	50.24M shares

Balance Sheet

Concept	2017 Q4	2017 Q3	2016 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$136.6M	$158.6M	$147.0M
YoY Change	-7.07%	8.41%	8.73%
Cash & Equivalents	$136.6M	$101.1M	$139.1M
Short-Term Investments	$0.00	$57.50M	$19.40M
Other Short-Term Assets	$2.900M	$3.500M	$14.70M
YoY Change	-80.27%	-80.66%	-2.65%
Inventory
Prepaid Expenses
Receivables	$153.0K	$300.0K	$26.75M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$139.7M	$162.4M	$188.5M
YoY Change	-25.89%	-25.53%	2.51%
LONG-TERM ASSETS
Property, Plant & Equipment			$127.0K
YoY Change			-53.31%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$2.195M	$2.284M	$0.00
YoY Change		34.35%
Other Assets	$207.0K	$382.0K	$618.0K
YoY Change	-66.5%	4.66%	-44.32%
Total Long-Term Assets	$169.1M	$278.8M	$107.5M
YoY Change	57.26%	164.46%	-34.45%
TOTAL ASSETS
Total Short-Term Assets	$139.7M	$162.4M	$188.5M
Total Long-Term Assets	$169.1M	$278.8M	$107.5M
Total Assets	$308.8M	$441.2M	$296.0M
YoY Change	4.31%	36.39%	-14.92%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$8.000M	$7.700M	$14.30M
YoY Change	-44.06%	-66.08%	-17.34%
Accrued Expenses			$0.00
YoY Change			-100.0%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$9.557M	$27.52M	$28.19M
YoY Change	-66.1%	-42.58%	-15.15%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$3.552M	$8.752M	$369.0K
YoY Change	862.6%	2317.68%	18.65%
Total Long-Term Liabilities	$3.552M	$8.752M	$369.0K
YoY Change	862.6%	2317.68%	18.65%
TOTAL LIABILITIES
Total Short-Term Liabilities	$9.557M	$27.52M	$28.19M
Total Long-Term Liabilities	$3.552M	$8.752M	$369.0K
Total Liabilities	$13.11M	$36.27M	$28.56M
YoY Change	-54.1%	-25.21%	-15.37%
SHAREHOLDERS EQUITY
Retained Earnings	-$320.0M	-$209.8M	-$342.2M
YoY Change	-6.48%	-36.72%	18.76%
Common Stock	$51.00K	$51.00K	$50.00K
YoY Change	2.0%	2.0%	-1.96%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$34.64M	$34.64M	$34.64M
YoY Change	0.0%	0.0%	0.0%
Treasury Stock Shares	1.729M shares	1.729M shares	1.729M shares
Shareholders Equity	$294.3M	$403.5M	$265.6M
YoY Change
Total Liabilities & Shareholders Equity	$308.8M	$441.2M	$296.0M
YoY Change	4.31%	36.39%	-14.92%

Cashflow Statement

Concept	2017 Q4	2017 Q3	2016 Q4
OPERATING ACTIVITIES
Net Income	-$110.2M	$158.5M	-$10.61M
YoY Change	938.57%	2137.57%	-90.85%
Depreciation, Depletion And Amortization	$5.400M	$5.700M	$6.300M
YoY Change	-14.29%	-12.31%	-52.27%
Cash From Operating Activities	-$21.90M	$40.20M	$10.90M
YoY Change	-300.92%	-375.34%	-190.08%
INVESTING ACTIVITIES
Capital Expenditures	$0.00		-$200.0K
YoY Change	-100.0%
Acquisitions
YoY Change
Other Investing Activities	$57.40M	-$2.400M	$900.0K
YoY Change	6277.78%	-70.37%
Cash From Investing Activities	$57.40M	-$2.400M	$700.0K
YoY Change	8100.0%	-70.37%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	100.0K	0.000	0.000
YoY Change		-100.0%	-100.0%
NET CHANGE
Cash From Operating Activities	-21.90M	40.20M	10.90M
Cash From Investing Activities	57.40M	-2.400M	700.0K
Cash From Financing Activities	100.0K	0.000	0.000
Net Change In Cash	35.60M	37.80M	11.60M
YoY Change	206.9%	-258.82%	-151.56%
FREE CASH FLOW
Cash From Operating Activities	-$21.90M	$40.20M	$10.90M
Capital Expenditures	$0.00		-$200.0K
Free Cash Flow	-$21.90M		$11.10M
YoY Change	-297.3%		-191.74%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2017Q2	actg	A10 Warrant A10Warrant	809400	shares
CY2017Q1	actg	Beneficial Ownership Percentage Limit BeneficialOwnershipPercentageLimit	0.60
CY2017Q1	actg	Bridge Installment Shares BridgeInstallmentShares	90000	shares
CY2017Q1	actg	Bridge Warrant Share BridgeWarrantShare	157000	shares
CY2017Q1	actg	Bridgeloanstatedinterestrate Bridgeloanstatedinterestrate	0.08
CY2016	actg	Cash Paidfor Investment CashPaidforInvestment	2250000	USD
CY2017Q2	actg	Cashpaidforprimarywarrantexercise Cashpaidforprimarywarrantexercise	29300000	USD
CY2017Q3	actg	Changeinfairvalueofcommonstock Changeinfairvalueofcommonstock	127150000	USD
	actg	Changeinfairvalueofcommonstock Changeinfairvalueofcommonstock	115381000	USD
CY2017Q3	actg	Changeinfairvalueofwarrants Changeinfairvalueofwarrants	31829000	USD
	actg	Changeinfairvalueofwarrants Changeinfairvalueofwarrants	30900000	USD
CY2016Q3	actg	Contingent Legal Fees ContingentLegalFees	7709000	USD
	actg	Contingent Legal Fees ContingentLegalFees	22236000	USD
CY2017Q3	actg	Contingent Legal Fees ContingentLegalFees	12173000	USD
	actg	Contingent Legal Fees ContingentLegalFees	16036000	USD
CY2017Q3	actg	Fair Valueof Profits Interest FairValueofProfitsInterest	8235000	USD
CY2017Q1	actg	Fair Valueof Profits Interest FairValueofProfitsInterest	722000	USD
CY2016Q3	actg	First Loan Warrant FirstLoanWarrant	700000	USD
CY2017Q3	actg	Gainlossoninvestmentnetofconversion Gainlossoninvestmentnetofconversion	158979000	USD
	actg	Gainlossoninvestmentnetofconversion Gainlossoninvestmentnetofconversion	153568000	USD
CY2016Q3	actg	Gainon Conversionof Loanand Accrued Interest GainonConversionofLoanandAccruedInterest	0	USD
	actg	Gainon Conversionof Loanand Accrued Interest GainonConversionofLoanandAccruedInterest	0	USD
CY2017Q3	actg	Gainon Conversionof Loanand Accrued Interest GainonConversionofLoanandAccruedInterest	0	USD
	actg	Gainon Conversionof Loanand Accrued Interest GainonConversionofLoanandAccruedInterest	2671000	USD
CY2016Q3	actg	Gainonexerciseof Primary Warrant GainonexerciseofPrimaryWarrant	0	USD
	actg	Gainonexerciseof Primary Warrant GainonexerciseofPrimaryWarrant	0	USD
CY2017Q3	actg	Gainonexerciseof Primary Warrant GainonexerciseofPrimaryWarrant	0	USD
	actg	Gainonexerciseof Primary Warrant GainonexerciseofPrimaryWarrant	-4616000	USD
CY2016Q3	actg	Generalandadministrativeexpensesexcludingsharebasedcompensation Generalandadministrativeexpensesexcludingsharebasedcompensation	5790000	USD
	actg	Generalandadministrativeexpensesexcludingsharebasedcompensation Generalandadministrativeexpensesexcludingsharebasedcompensation	18109000	USD
CY2017Q3	actg	Generalandadministrativeexpensesexcludingsharebasedcompensation Generalandadministrativeexpensesexcludingsharebasedcompensation	3262000	USD
	actg	Generalandadministrativeexpensesexcludingsharebasedcompensation Generalandadministrativeexpensesexcludingsharebasedcompensation	13297000	USD
	actg	Increase Decrease In Royalties And Contingent Legal Fees Payable IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable	10131000	USD
	actg	Increase Decrease In Royalties And Contingent Legal Fees Payable IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable	5916000	USD
	actg	Investmentat Fair Value Purchasesand Issues InvestmentatFairValuePurchasesandIssues	55228000	USD
CY2016Q4	actg	Investmentsatfairvalue Investmentsatfairvalue	0	USD
CY2017Q3	actg	Investmentsatfairvalue Investmentsatfairvalue	208796000	USD
CY2016Q4	actg	Investmentwarrants Investmentwarrants	1960000	USD
CY2017Q3	actg	Investmentwarrants Investmentwarrants	0	USD
CY2016Q3	actg	Litigation And Licensing Expenses Patents LitigationAndLicensingExpensesPatents	7348000	USD
	actg	Litigation And Licensing Expenses Patents LitigationAndLicensingExpensesPatents	22895000	USD
CY2017Q3	actg	Litigation And Licensing Expenses Patents LitigationAndLicensingExpensesPatents	4073000	USD
	actg	Litigation And Licensing Expenses Patents LitigationAndLicensingExpensesPatents	14593000	USD
CY2017Q3	actg	Lossonfairvalueinvestmentnet Lossonfairvalueinvestmentnet	158979000	USD
	actg	Lossonfairvalueinvestmentnet Lossonfairvalueinvestmentnet	153568000	USD
CY2016Q3	actg	Maximum Investmentin Veritone MaximumInvestmentinVeritone	50000000	USD
CY2016Q3	actg	Noncashstockcompensationgeneralandadministrative Noncashstockcompensationgeneralandadministrative	2544000	USD
	actg	Noncashstockcompensationgeneralandadministrative Noncashstockcompensationgeneralandadministrative	5754000	USD
CY2017Q3	actg	Noncashstockcompensationgeneralandadministrative Noncashstockcompensationgeneralandadministrative	1272000	USD
	actg	Noncashstockcompensationgeneralandadministrative Noncashstockcompensationgeneralandadministrative	4833000	USD
CY2016Q3	actg	Noncashstockcompensationprofitsinterests Noncashstockcompensationprofitsinterests	0	USD
	actg	Noncashstockcompensationprofitsinterests Noncashstockcompensationprofitsinterests	0	USD
CY2017Q3	actg	Noncashstockcompensationprofitsinterests Noncashstockcompensationprofitsinterests	8181000	USD
	actg	Noncashstockcompensationprofitsinterests Noncashstockcompensationprofitsinterests	8235000	USD
CY2013	actg	Numberofpatentportfoliosacquired Numberofpatentportfoliosacquired	25	patents
CY2014	actg	Numberofpatentportfoliosacquired Numberofpatentportfoliosacquired	6	patents
CY2015	actg	Numberofpatentportfoliosacquired Numberofpatentportfoliosacquired	3	patents
CY2016	actg	Numberofpatentportfoliosacquired Numberofpatentportfoliosacquired	2	patents
	actg	Numberofpatentportfoliosacquired Numberofpatentportfoliosacquired	1	patents
CY2016Q4	actg	Patents Accumulated Amortization PatentsAccumulatedAmortization	358043000	USD
CY2017Q3	actg	Patents Accumulated Amortization PatentsAccumulatedAmortization	376777000	USD
CY2016Q4	actg	Patents Net Of Accumulated Amortization PatentsNetOfAccumulatedAmortization	86319000	USD
CY2017Q3	actg	Patents Net Of Accumulated Amortization PatentsNetOfAccumulatedAmortization	67360000	USD
CY2016Q3	actg	Research Consulting And Other Expenses Business Development ResearchConsultingAndOtherExpensesBusinessDevelopment	666000	USD
	actg	Research Consulting And Other Expenses Business Development ResearchConsultingAndOtherExpensesBusinessDevelopment	2522000	USD
CY2017Q3	actg	Research Consulting And Other Expenses Business Development ResearchConsultingAndOtherExpensesBusinessDevelopment	241000	USD
	actg	Research Consulting And Other Expenses Business Development ResearchConsultingAndOtherExpensesBusinessDevelopment	994000	USD
CY2016Q4	actg	Royalties And Contingent Legal Fees Payable RoyaltiesAndContingentLegalFeesPayable	13908000	USD
CY2017Q3	actg	Royalties And Contingent Legal Fees Payable RoyaltiesAndContingentLegalFeesPayable	19824000	USD
CY2016Q3	actg	Secured Convertible Promissory Note SecuredConvertiblePromissoryNote	20000000	USD
CY2016Q3	actg	Secured Promissory Note Advance SecuredPromissoryNoteAdvance	10000000	USD
CY2017Q2	actg	Unamortizedloandiscount Unamortizedloandiscount	1700000	USD
CY2017Q1	actg	Upfront Shares UpfrontShares	60000	shares
CY2017Q1	actg	Veritone Bridge Loan Advance1 VeritoneBridgeLoanAdvance1	1000000	USD
CY2017Q1	actg	Veritone Bridge Loan Advance3and4 VeritoneBridgeLoanAdvance3and4	2000000	USD
CY2016Q3	actg	Veritone Primary Warrant VeritonePrimaryWarrant	50000000	USD
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2017
	dei	Document Period End Date DocumentPeriodEndDate	2017-09-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0000934549
CY2017Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	50604782	shares
	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	ACACIA RESEARCH CORP
CY2016Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	14283000	USD
CY2017Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	7691000	USD
CY2016Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	26750000	USD
CY2017Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	300000	USD
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	630000	USD
CY2016Q4	us-gaap	Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-76000	USD
CY2017Q3	us-gaap	Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-38000	USD
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4410974	shares
	us-gaap	Acquired Finite Lived Intangible Assets Weighted Average Useful Life AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife	P4Y
CY2016Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	642453000	USD
CY2017Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	647930000	USD
CY2016Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	6467000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	27986000	USD
CY2017Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	5625000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	16711000	USD
CY2016Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3593708	shares
CY2017Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	6029156	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4618618	shares
CY2016Q4	us-gaap	Assets Assets	296003000	USD
CY2017Q3	us-gaap	Assets Assets	441210000	USD
CY2016Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	19403000	USD
CY2017Q3	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	57427000	USD
CY2016	us-gaap	Available For Sale Securities Gross Unrealized Gains AvailableForSaleSecuritiesGrossUnrealizedGains	40000	USD
	us-gaap	Available For Sale Securities Gross Unrealized Gains AvailableForSaleSecuritiesGrossUnrealizedGains	60000	USD
CY2016	us-gaap	Available For Sale Securities Gross Unrealized Loss AvailableForSaleSecuritiesGrossUnrealizedLoss	0	USD
	us-gaap	Available For Sale Securities Gross Unrealized Loss AvailableForSaleSecuritiesGrossUnrealizedLoss	0	USD
CY2017Q1	us-gaap	Bridge Loan BridgeLoan	4000000	USD
CY2017Q2	us-gaap	Bridge Loan BridgeLoan	4000000	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	135223000	USD
CY2016Q4	us-gaap	Assets Current AssetsCurrent	188490000	USD
CY2017Q3	us-gaap	Assets Current AssetsCurrent	162388000	USD
CY2016Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	19443000	USD
CY2017Q3	us-gaap	Available For Sale Securities AvailableForSaleSecurities	57487000	USD
CY2016Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	116016000	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	127540000	USD
CY2017Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	101081000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-19207000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-26459000	USD
CY2016Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2017Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2016Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2017Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2016Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2017Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2016Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	50476042	shares
CY2017Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	50604782	shares
CY2016Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	50476042	shares
CY2017Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	50604782	shares
CY2016Q4	us-gaap	Common Stock Value CommonStockValue	50000	USD
CY2017Q3	us-gaap	Common Stock Value CommonStockValue	51000	USD
CY2016Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	7194000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-43300000	USD
CY2017Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	158489000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	132421000	USD
CY2016Q3	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	7008000	USD
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-43766000	USD
CY2017Q3	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	158393000	USD
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	132022000	USD
CY2017Q2	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	13.6088
CY2017Q3	us-gaap	Deferred Tax Liabilities Investments DeferredTaxLiabilitiesInvestments	54108000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	28105000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	16780000	USD
CY2016Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.14
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.87
CY2017Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	3.13
	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	-22000	USD
CY2017Q3	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	0	USD
	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	0	USD
CY2017Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	11453000	USD
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.61
CY2016Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.58
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.56
CY2016Q4	us-gaap	Equity Method Investments EquityMethodInvestments	0	USD
CY2017Q3	us-gaap	Equity Method Investments EquityMethodInvestments	2284000	USD
CY2017Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.00
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.02
CY2016Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	0	USD
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.62
CY2016Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.14
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.87
CY2017Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	3.13
CY2017Q3	us-gaap	Equity Method Investment Ownership Percentage EquityMethodInvestmentOwnershipPercentage	0.23
CY2017Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	208796000	USD
CY2017Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	5443000	USD
CY2017Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	5261000	USD
CY2017Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	6134000	USD
CY2017Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	18527000	USD
CY2017Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	20542000	USD
CY2017Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	67360000	USD
CY2016Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	8334000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	23863000	USD
CY2017Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	12715000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	26365000	USD
CY2016Q3	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0	USD
	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	40165000	USD
	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	40165000	USD
CY2017Q3	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	2248000	USD
	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	2248000	USD
	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	2248000	USD
CY2016Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	16551000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-28148000	USD
CY2017Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	158585000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	134919000	USD
CY2016Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	0	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	0	USD
CY2017Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-116000	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-130000	USD
CY2016Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	9655000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	15774000	USD
CY2017Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	216000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2935000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	5392000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-6608000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	20200000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-26450000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1191000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	874000	USD
	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	3316000	USD
	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	-11512000	USD
CY2016Q4	us-gaap	Liabilities Liabilities	28560000	USD
CY2017Q3	us-gaap	Liabilities Liabilities	36267000	USD
CY2016Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	296003000	USD
CY2017Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	441210000	USD
CY2016Q4	us-gaap	Liabilities Current LiabilitiesCurrent	28191000	USD
CY2017Q3	us-gaap	Liabilities Current LiabilitiesCurrent	27515000	USD
CY2016Q3	us-gaap	Licenses Revenue LicensesRevenue	64658000	USD
	us-gaap	Licenses Revenue LicensesRevenue	130730000	USD
CY2017Q3	us-gaap	Licenses Revenue LicensesRevenue	36633000	USD
	us-gaap	Licenses Revenue LicensesRevenue	61944000	USD
CY2016Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	16000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	42000	USD
CY2017Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	15000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	20000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	35000	USD
CY2016Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	0	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	0	USD
CY2017Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	0	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	0	USD
CY2016Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	369000	USD
CY2016Q4	us-gaap	Long Term Investments And Receivables Net LongTermInvestmentsAndReceivablesNet	18616000	USD
CY2017Q3	us-gaap	Long Term Investments And Receivables Net LongTermInvestmentsAndReceivablesNet	0	USD
CY2017Q2	us-gaap	Long Term Investments And Receivables Net LongTermInvestmentsAndReceivablesNet	20736000	USD
CY2016Q4	us-gaap	Minority Interest MinorityInterest	1854000	USD
CY2017Q3	us-gaap	Minority Interest MinorityInterest	1455000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1141000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	645000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-41285000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-73539000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	23219000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	46435000	USD
CY2016Q3	us-gaap	Net Income Loss NetIncomeLoss	7082000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-43456000	USD
CY2017Q3	us-gaap	Net Income Loss NetIncomeLoss	158465000	USD
	us-gaap	Net Income Loss NetIncomeLoss	132383000	USD
CY2016Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-186000	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-466000	USD
CY2017Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-96000	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-399000	USD
CY2016Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	7043000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-43456000	USD
CY2017Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	158326000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	132142000	USD
CY2016Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	7043000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-43456000	USD
CY2017Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	158326000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	132143000	USD
CY2016Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	261000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	206000	USD
CY2017Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	159027000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	154861000	USD
CY2016Q3	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	48368000	USD
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	159084000	USD
CY2017Q3	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	37075000	USD
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	81886000	USD
CY2016Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	16290000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-28354000	USD
CY2017Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-442000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-19942000	USD
CY2016Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	618000	USD
CY2017Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	382000	USD
CY2016Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	96000	USD
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	92000	USD
CY2017Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	9000	USD
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	18000	USD
CY2016Q3	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	0	USD
CY2017Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	8752000	USD
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	0	USD
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	23061000	USD
CY2016Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	261000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	206000	USD
CY2017Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	164000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1423000	USD
	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	-81000	USD
	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	-473000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	25000	USD
	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments	31514000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	4000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	0	USD
	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	62633000	USD
	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	424945000	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	1000000	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	0	USD
	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	10000000	USD
	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	4000000	USD
	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments	0	USD
	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	1358000	USD
	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	0	USD
CY2016Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2017Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2016Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2017Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2016Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2017Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2016Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2017Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2016Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	146281000	USD
CY2016Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	494455	shares
CY2017Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2016Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3245000	USD
CY2017Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3520000	USD
	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	32352000	USD
	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	386920000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	242000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	680000	USD
CY2016Q3	us-gaap	Profit Loss ProfitLoss	6896000	USD
	us-gaap	Profit Loss ProfitLoss	-43922000	USD
CY2017Q3	us-gaap	Profit Loss ProfitLoss	158369000	USD
	us-gaap	Profit Loss ProfitLoss	131984000	USD
CY2016Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	11512000	USD
CY2017Q3	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	0	USD
CY2016Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-342198000	USD
CY2017Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-209815000	USD
CY2016Q3	us-gaap	Royalty Expense RoyaltyExpense	17844000	USD
	us-gaap	Royalty Expense RoyaltyExpense	19417000	USD
CY2017Q3	us-gaap	Royalty Expense RoyaltyExpense	0	USD
	us-gaap	Royalty Expense RoyaltyExpense	4939000	USD
CY2016Q3	us-gaap	Share Based Compensation ShareBasedCompensation	2544000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	5754000	USD
CY2017Q3	us-gaap	Share Based Compensation ShareBasedCompensation	9453000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	13068000	USD
CY2016Q4	us-gaap	Short Term Investments ShortTermInvestments	19443000	USD
CY2017Q3	us-gaap	Short Term Investments ShortTermInvestments	57487000	USD
CY2016Q4	us-gaap	Stockholders Equity StockholdersEquity	265589000	USD
CY2017Q3	us-gaap	Stockholders Equity StockholdersEquity	403488000	USD
CY2016Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	267443000	USD
CY2017Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	404943000	USD
CY2016Q3	us-gaap	Timesharing Transactions Stated Interest Rate For Notes Receivable TimesharingTransactionsStatedInterestRateForNotesReceivable	0.06
CY2016Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	1729408	shares
CY2017Q3	us-gaap	Treasury Stock Shares TreasuryStockShares	1729408	shares
CY2016Q4	us-gaap	Treasury Stock Value TreasuryStockValue	34640000	USD
CY2017Q3	us-gaap	Treasury Stock Value TreasuryStockValue	34640000	USD
CY2016Q3	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	39000	USD
	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	0	USD
CY2017Q3	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	139000	USD
	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	241000	USD
CY2016Q3	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Diluted UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted	0	USD
	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Diluted UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted	0	USD
CY2017Q3	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Diluted UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted	0	USD
	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Diluted UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted	1000	USD
CY2016Q3	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	0	USD
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	0	USD
CY2017Q3	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	158979000	USD
CY2017Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	45740	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	221735	shares
CY2016Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	50618757	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	50024047	shares
CY2017Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	50599974	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	50684725	shares
CY2016Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	50124302	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	50024047	shares
CY2017Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	50554234	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	50462990	shares
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Concentrations. </font><font style="font-family:inherit;font-size:10pt;">One</font><font style="font-family:inherit;font-size:10pt;"> licensee individually accounted for </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">96%</font><font style="font-family:inherit;font-size:10pt;"> of revenues recognized during the three months ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;font-weight:normal;text-decoration:none;">September 30, 2017</font><font style="font-family:inherit;font-size:10pt;">, and three licensees accounted for </font><font style="font-family:inherit;font-size:10pt;">57%</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">23%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">10%</font><font style="font-family:inherit;font-size:10pt;"> of revenues recognized during the nine months ended September 30, 2017. Two licensees individually accounted for </font><font style="font-family:inherit;font-size:10pt;">60%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">27%</font><font style="font-family:inherit;font-size:10pt;"> of revenues recognized during the three months ended September 30, 2016, and three licensees accounted for </font><font style="font-family:inherit;font-size:10pt;">30%</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">27%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">13%</font><font style="font-family:inherit;font-size:10pt;"> of revenues recognized during the nine months ended September 30, 2016. For the three and nine months ended </font><font style="font-family:inherit;font-size:10pt;">September 30, 2017</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">3%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">39%</font><font style="font-family:inherit;font-size:10pt;">, respectively, of revenues were attributable to licensees domiciled in foreign jurisdictions, based on the jurisdiction of the entity obligated to satisfy payment obligations pursuant to the applicable revenue arrangement. For the three and nine months ended September 30, 2016, </font><font style="font-family:inherit;font-size:10pt;">93%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">78%</font><font style="font-family:inherit;font-size:10pt;">, respectively, of revenues were attributable to licensees domiciled in foreign jurisdictions. The Company does not have any material foreign operations. One licensee individually represented approximately </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;text-decoration:none;">100%</font><font style="font-family:inherit;font-size:10pt;"> of accounts receivable at </font><font style="font-family:inherit;font-size:10pt;color:#000000;font-weight:normal;text-decoration:none;">September 30, 2017</font><font style="font-family:inherit;font-size:10pt;">. Four licensees individually represented approximately </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;text-decoration:none;">39%</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;text-decoration:none;">22%</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">16%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">15%</font><font style="font-family:inherit;font-size:10pt;"> of accounts receivable at December 31, 2016. </font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div>
	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Use of Estimates.  </font><font style="font-family:inherit;font-size:10pt;">The preparation of condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amount of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates. Acacia believes that, of the significant accounting policies described herein, the accounting policies associated with revenue recognition, the valuation of the loan and equity instruments discussed at Note 5, stock-based compensation expense, impairment of patent-related intangible assets, the determination of the economic useful life of amortizable intangible assets, income taxes and valuation allowances against net deferred tax assets, require its most difficult, subjective or complex judgments.</font></div></div>

Files In Submission

Name	View Source	Status
0000934549-17-000055-index-headers.html	Edgar Link	pending
0000934549-17-000055-index.html	Edgar Link	pending
0000934549-17-000055.txt	Edgar Link	pending
0000934549-17-000055-xbrl.zip	Edgar Link	pending
actg-20170930.xml	Edgar Link	completed
actg-20170930.xsd	Edgar Link	pending
actg-20170930_cal.xml	Edgar Link	unprocessable
actg-20170930_def.xml	Edgar Link	unprocessable
actg-20170930_lab.xml	Edgar Link	unprocessable
actg-20170930_pre.xml	Edgar Link	unprocessable
actg10q09302017.htm	Edgar Link	pending
ex10109302017.htm	Edgar Link	pending
ex31109302017.htm	Edgar Link	pending
ex31209302017.htm	Edgar Link	pending
ex32109302017.htm	Edgar Link	pending
ex32209302017.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
graphicactga02a08.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ACTG
ACACIA RESEARCH CORP Stock $actg

2017 Q4 Form 10-Q Financial Statement

#000093454917000055 Filed on November 07, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ACTG ACACIA RESEARCH CORP Stock $actg

2017 Q4 Form 10-Q Financial Statement

#000093454917000055 Filed on November 07, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ACTG
ACACIA RESEARCH CORP Stock $actg